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Introduction
Worldwide interest in natural products as preventive and 
therapeutic agent has given a greater appreciation of the rich 
cultural heritage of traditional medicinal system (Chaturvedi 
et al., 2007). Potential bioactive phytocompounds lead to 
the development of new therapeutic drugs emphasizing the 
need of scientific analysis of herbs with pharmacological 
effects to discover new active compounds (Falcao et al., 
2008). Consumption of citrus fruits decreases the risk of 
cancer, inflammation, heart disease and ulcers, which has 
increased their use as precursors of flavonoids. Citrus juice 
is considered to be a rich source of antioxidants, including 
vitamin C, phenolic compounds and carotenoids, which have 
ARTICLE INFO
Article history:
Received 21 November 2013
Accepted 10 February 2014
Keywords:
Antioxidant
Flavonoid
Citrus sinensis
Cytoprotective
Hesperidin 
A B S T R A C T
Free radicals play an important role in stomach ulcer formation. The present investigation 
validates the anti ulcer activity of hesperidin, isolated from Citrus sinensis (L.) Osbeck, 
Rutaceae, through the assessment of its antioxidant potential over stomach mucosal tissue 
by histological examination. Hesperidin was isolated from the dried peel of C. sinensis, 
and authenticated by TLC, IR and HPLC. The anti-ulcerogenic potential of this fruit was 
assessed using indomethacin and hypothermic restrain stress-induced ulceration models 
on rats at 150, 300 and 450 mg/kg dose orally. The parameters measured were gastric pH, 
volume, free and total acidity, ulcer index, and mucin, glutathione, super oxide dismutase, 
catalase and protein content. Hesperidin at 300 and 450 mg/kg dose showed significant 
(p < 0.01-0.001) increase in pH, decrease in acidity and ulcer index against indomethacin 
and hypothermic restrain stress, along with histological evidence of cytoprotection. 
Glutathione, super oxide dismutase, catalase and mucin levels increased significantly at 450 
mg/kg (p < 0.05-0.001) after indomethacin ulceration, whereas hypothermic restrain stress 
only increased glutathione and mucin levels. Hesperidin prevents oxidative cell injury by 
significant rise of super oxide dismutase, glutathione and catalase levels in gastric mucosa. 
Hesperidin allowed the regeneration of ulcerated tissue, and prevented hemorrhagic injury 
of gastric mucosa.  The potential anti-ulcer effect of hesperidin may be due to antioxidant, 
mucoprotective and cytoprotective activities.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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many health benefits (Gattuso et al., 2007). Citrus herbal 
products prepared from mature or immature citrus peels 
have been traditionally used for liver rejuvenation (Dan and 
Andrew, 1986). During the processing of citrus fruit in juice 
and other food industries, peels are the primary byproducts, 
normally discarded after consuming the fruits. Many studies 
have shown that bioactive flavonoids present in the citrus peel 
possess strong antioxidant, antiatherogenic, anti-viral, anti-
aggregation, anti-mutagenic, anti-ulcer and antitumor effects 
(Del-Rio et al., 1992; Zia, 2006; Parmar and Kar, 2008). 
Flavonoids are a group of about 4,000 naturally occurring 
compounds that have a wide range of biological effects, 
including anti-ulcer activity. Plants synthesize flavonoids 
as an adaptive response to stress conditions (infection, 
wounding, water stress, cold stress). In recent years flavonoids 
have attracted the interest of researchers because they have 
promising powerful antioxidant properties that protect the 
human body from free radicals by their hydrogen donating 
abilities (Jeong et al., 2007). They are important constituents 
of the human diet (a daily diet should provide approximately 
1 g of flavonoids per day) and are also found in several 
medicinal plants used in folk medicine around the world. 
Many epidemiological studies have shown that consumption 
of plants rich in phenolic compounds is associated with a lower 
risk of degenerative diseases such as cancer (Harris et al., 2007), 
cardiovascular disease (Naruszewicz et al., 2007), immune 
dysfunction (Kale et al., 2008) and allergic (Sokmen et al., 2004) 
complications. Free radicals play an important role in ulcer 
formation and erosive lesions in the gastrointestinal tract. 
Flavonoids like naringin, quercetin, silymarin, anthocyanosides 
and sophoradin derivatives have been reported to have anti-
ulcer properties (Borrelli and Izzo, 2000). 
Citrus sinensis (L.) Osbeck, Rutaceae, is a small, shallow-
rooted evergreen shrub or tree about 6-13 m high with an 
enclosed conical top and mostly spiny branches. Leaves are 
smooth, oval, dark green and glossy, with a distinctive smell 
often similar to the fruit. Fruits are reddish-green to yellowish-
green, round, 4-12 cm in diameter, and have a leathery peel 
6 mm thick, tightly adherent, protecting the juicy inner pulp 
(Anonymous, 2006). Hesperidin (1) is a flavanone glycoside 
found abundantly in sweet orange and lemon, and is an 
inexpensive by-product of citrus products (Garg et al., 2001). 
Hesperidin may be associated with potential benefits for the 
prevention of diseases, like decreased capillary permeability, 
inflammation, microbial infection and carcinogenic effects. A 
number of researchers have examined the antioxidant activity 
and radical scavenging properties of hesperidin using a variety 
of assay systems (Orallo et al., 2004; Hirata et al., 2005; Cho, 
2006).
Rossi et al. (1957) reported the effect of hesperidin on 
histamine-induced gastric ulcers in guinea pigs. Hesperidin 
(1) and neohesperidin dihydrochalcone allowed reduction of 
cold restraint-induced ulcer, but was ineffective on absolute 
ethanol-induced ulcer (Suárez et al., 1996). Lee et al. (2009) 
reported the inhibitory effect of neohesperidin and poncirin, 
isolated from Poncirus trifoliata, against HCl/ethanol-induced 
gastric lesions. Furthermore, Ping-Wei San, a Chinese decoction 
containing hesperidin, reduced gastric ulceration induced 
by indomethacin (Cheng et al., 2011). These reports showed 
experimental evidence of the beneficial effects of hesperidin 
against peptic ulcer. The present investigation was carried out 
to validate the anti-ulcer activity of hesperidin isolated from 
C. sinensis assessing its antioxidative potential in stomach 
mucosal tissue, along with histological examination of stomach 
mucosa, to evaluate the regenerative and cytoprotective effect 
on damaged mucosa. The present investigation was carried out 
to test and validate the anti-ulcer activity of hesperidin isolated 
from C. sinensis on two gastric ulcer models. The ulcer models 
used were, indomethacin to induce oxidative damage by 
inhibition of in situ synthesis of cytoprotective prostaglandins 
in stomach mucosa; and cold restrain to induce physiological 
stress related to the autonomic nervous system. 
Materials and methods
Collection and authentication
The fresh fruits of Citrus sinensis (L.) Osbeck, Rutaceae, were 
collected from November between December, 2010 at Bhopal 
(M.P). The botanical identity was confirmed from Saifia College 
of Science, Peer Gate, Bhopal (M.P.), by Prof. Ziaul Hassan and 
sample stored for future reference with authentication no. 192/ 
BOT/ SAIFIA/ 2010. Macroscopic characteristics of the fresh and 
dried peels were noted. Chopped green peels were dried for 
36 h under the sunlight, followed by shade drying. Dried peels 
were powdered in a mixture grinder, packed in paper bags and 
stored in an air tight container until use.
Drugs and chemicals
Drug samples of omeprazole and indomethacin were obtained 
from Dr. Reddy’s Laboratory, Hyderabad and Jagsonpal 
Pharmaceutical Ltd., New Delhi respectively. Hesperidin 
standard and Ehrlich’s reagent were purchased from Himedia 
Lab, Mumbai. Tris buffer, sodium di-hydrogen phosphate 
(NaH2PO4), trichloroacetic acid (TCA), disodium hydrogen 
phosphate (Na2HPO4) and poly-ethylene glycol-400 were 
purchased from E. Merck, Mumbai. The source of 5.5’-dithio 
bis-2-nitrobenzoic acid (DTNB) was Sigma-Aldrich, Sweden. 
Alcian blue, thiobarbituric acid and ruthenium red was 
procured from Loba Chemie Pvt. Ltd, Mumbai and all other 
solvents and reagents obtained were of GR grade.
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Extraction and isolation of hesperidin
Dried powdered peel was placed in a reflux condenser with 
petroleum ether for 1 h, filtered, dried at room temperature, 
and the yield was calculated. Methanol extract was subjected 
to phytochemical evaluation for alkaloids, tannins, phenolics, 
saponins, carbohydrates, steroids, flavonoids and glycosides, 
following the method of Kokate et al. (2001). Peel extract was 
re-extracted with methanol for 3 h, filtered and washed with 
hot methanol. Filtrate was concentrated and dried. Dried residue 
was mixed with 50 ml of 6% acetic acid to precipitate crude 
hesperidin (1). Crude hesperidin was filtered using a Buchner 
funnel, washed with 6% acetic acid, dried to constant weight.
Purification of hesperidin
Dimethylformamide was added to crude hesperidin (7 ml/g) 
prepared by warming it at 60°C and treated for 30 min. with 
activated charcoal previously boiled with dilute hydrochloric 
acid. Glacial acetic acid was added to the formamide solution to 
make it slightly acidic. The solution was then filtered through 
a celite filter, diluted with an equal volume of water, and was 
allowed to stand for a few hours in order to crystallize. The 
crystals of hesperidin were filtered, washed with hot water and 
the percentage yield was calculated (Ikan, 1991).
The isolated hesperidin was subjected to ferric chloride test 
and magnesium-hydrochloric acid reduction test (Shinoda 
test) following the method of Hendrickson and Kesterson 
(Hendrickson and Kesterson, 1954).
Authentication of hesperidin 
Preparation of stock solution
Hesperidin powder (standard and isolated) 12.5 mg was 
dissolved in 5 ml of dimethyl sulfoxide (DMSO), diluted with 
20 ml of methanol, and filtered through Whatman filter paper 
to recover  a hesperidin solution of 500 μg/ml.
Thin layer chromatography (TLC)
Plates freshly coated with Silica Gel G254 were allowed to air dry 
at room temperature, transferred to an oven for activation, and 
kept at 110°C for 30 min. Commonly used solvent system for 
identification and quantification flavonoids, n-butanol:acetic 
acid:water (4:1:5) was used for co-thin layer chromatograph to 
compare Rf values of standard and isolated hesperidin (Nataraj 
et al., 2009). Stock solution (20 μl) was spotted; plates were 
placed into the developing chamber and allowed to run until 
it reached a height of about 10 cm from the point of spotting. 
Methanol sulphuric acid (10%) was used as a spraying agent. 
After development, the plates were kept in an oven maintained 
at 110°C in order to achieve optimal color development.
Identification of hesperidin
Melting point was determined with the help of a digital melting 
point apparatus (Microteknik, India). Hesperidin stock solution 
1 ml was diluted to 10 ml with methanol to get a solution of 50 
μg/ml c and UV spectra were assessed with a Shimadzu (UV-
1800 Pharmaspec, Japan) spectrophotometer. The IR spectra 
were recorded on a Shimadzu (Bruker ALPHA-FTIR, Germany) 
spectrometer using a KBr pellet at a scanning speed of 2 mm/s 
and with resolution set at 4 cm−1.
HPLC of hesperidin
The chromatography analysis was performed on a Shimadzu 
(Japan) liquid chromatography system, equipped with 
ProMinent (LC-20AD) pump, SPD-M20A photodiode array UV/
VIS detector working in the range 190-800 nm, a quaternary 
solvent delivery system, degasser (DGU-20A5) and a rheodyne 
injection valve fitted with a 20 μl injection loop. The 
chromatographic data was recorded and processed with LC 
solution integrated software. Baseline resolution of hesperidin 
was obtained at 25 ± 2°C using stainless steel Luna column 
(250 mm × 4.6 mm), packed with octadecylsilane bonded to 
porous silica (5 μm). A secondary gradient solvent system 
consisting of 2% (v/v) of aqueous glacial acetic acid, pH 2.58 
(A) and acetonitrile (B) in a A:B ratio of 100%: 0% for initial 0-15 
min followed by A 100-70%: B 0-30% in 15-45 min was used. 
The mobile phase was passed through 0.45 PVDF filter, and 
degassed before use. The 20 μl sample solution (50 μg/ml) was 
injected; flow rate was kept constant at 1 ml/min with oven 
temperature 40°C and effluents monitored at 285 nm following 
the slightly modified method of Gorinstein et al. (2006). 
Pharmacological study 
Experimental animals
Laboratory-bred healthy Wistar rats of both sexes, weighing 
between 180-250 g. Animals were kept in laboratory conditions 
at 24 ± 2°C, relative humidity 60 ± 5%, 12:12 photoperiodic 
condition, in well ventilated animal house in polypropylene 
cages with paddy husk as bedding and access to food and 
water ad libitum. During the experimental period the animals 
were fed standard feeding pellets procured from Hindustan 
Lever, India. The experimental protocol was approved by the 
Institutional Animal Ethical Committee (IACE/RCP/Oct 2010/10), 
at Radharaman College of Pharmacy, Bhopal (M.P). All conditions 
were in accordance to CPCSEA norms and “WHO guidelines for 
the care and use of animals in scientific research”.
Preparation of test and standard drug suspension
Hesperidin was moderately solubilized in water, the test 
sample was prepared as an aqueous suspension using 0.25% 
Tween-80. Omeprazole and indomethacin were given as oral 
suspensions using 1% aqueous CMC.
Acute toxicity study
The LD50 was determined according to the guidelines of 
Organization for Economic Co-operation and Development 
(OECD), following the up and down method (OECD guideline Nº 
423). A limit test was performed at 2000 mg/kg, p.o. to categorize 
the toxicity class (LD50) of hesperidin (Diener et al., 1995). 
Indomethacin induced gastric ulcers
Rats were randomly divided in six groups of six subjects each, 
subjected to 24 h of fasting and orally treated as follows.
Group I: Vehicle control (1% CMC 0.5 ml/100 g)
Group II:  Indomethacin (25 mg/kg) 
Group III: Indomethacin + omeprazole (20 mg/kg) 
 Papiya Bigoniya et al. / Rev Bras Farmacogn 24(2014): 330-340 333
> 3 but < 5mm and 3 for ulcer > 5mm. Mean ulcer score for each 
animal was expressed as ulcer index. The percentage healing 
was calculated as:
Percent inhibition = Ulcer area of control − Ulcer area of treated 
× 100/Ulcer area of control
Morphological examination
The stomach was opened and washed with running tap 
water, placed on a flat glass plate to view the morphological 
alterations induced by different treatments. Photographs were 
taken using digital camera (10 mega pixel 5× zoom).
Histopathological evaluation
Gastric tissue samples were fixed in neutral buffered formalin 
for 24 h. The washed tissues were embedded in paraffin blocks 
and sections of 5 μm thick were cut using an optical rotary 
microtome. The sections were stained with haematoxylin 
and eosin (Nanji et al., 2002). The slides were examined 
microscopically for pathomorphological changes such as 
congestion, hemorrhage, edema, and erosions using an 
arbitrary scale for severity assessment for these changes.
Estimation of biochemical parameters
Stomach tissue was homogenized in ice cold 0.15 M Tris-HCl 
(pH 7.4) to give 10% w/v homogenate. The homogenate was 
then centrifuged at 10000g for 15 min at 4°C in a refrigerated 
centrifuge (Remi, India). Supernatant was collected for GSH, 
SOD, catalase and protein content determination.
Glutathione reduces H2O2 directly to water or reacts 
directly with free radicals such as O2*, OH*, O
-* by a radical 
transfer process, which yields thiol radicals. These thiol 
radicals, present in glutathione, form a colored complex with 
DTNB, which is measured colorimetrically at 412 nm (Tietze, 
1969). One enzymatic unit of SOD is the amount of protein in 
the form of enzyme present in 100 μl of sample, required to 
inhibit the reduction of 24 micromolar nitro-blue tetrazolium 
(NBT) by 50%, and is expressed as unit/mg of protein. All these 
estimations were done using a Shimadzu (UV-1800 pharmaspec) 
spectrophotometer. Superoxide dismutase was estimated 
following the method of Misra and Fridovich (1979). Catalase 
was determined following the method of Aebi (Aebi, 1983). 
Decomposition of H2O2 by catalase is directly proportional to 
decrease in absorbance at 340 nm. The results were expressed as 
unit of H2O2 decomposed/min/mg of protein, using 71 as molar 
extinction coefficient of H2O2. The total protein content was 
measured following method of Lowry et al. (1951). 
Mucin content in gastric wall mucus was determined 
according to the modified procedure of Corne et al. (1974). 
Some glandular segments of stomach were removed and 
weighed and transferred immediately to 10 ml of 0.1% w/v 
Alcian blue solution (0.16 M sucrose solution, buffered with 
0.05 M sodium acetate pH 5) for 2 h immersion. Excess dye was 
removed by two successive rinses with 10 ml of 0.25 M sucrose, 
dye complexed with the mucus was extracted with 10 ml of 0.5 
M magnesium chloride by shaking intermittently for 2 h. The 
blue extract was then shaken vigorously with an equal volume 
of diethyl ether a resulting emulsion was centrifuged at 3600 g 
for 10 min. The absorbance of the aqueous layer was recorded 
Group IV: Indomethacin + hesperidin (150 mg/kg)
Group V: Indomethacin + hesperidin (300 mg/kg)
Group VI: Indomethacin + hesperidin (450 mg/kg)
Indomethacin was administered to all the animals from 
Group II to VI, 30 min before omeprazole (Group III) and 
hesperidin 150, 300 and 450 mg/kg (Group IV-VI) treatment. 
Vehicle control group was treated only with 1% CMC (0.5 
ml/100 g). Under light ether anesthesia, after 6 h all animals 
were sacrificed by decapitation, and the stomach was isolated 
after suturing the lower esophageal end (Dengiz and Gursan, 
2005). The stomach was cut open along the greater curvature, 
gastric contents were collected in a graduated centrifuge 
tube to measure pH, volume, and total and free acidity. The 
stomach surface was cleaned with cold normal saline solution 
to determine ulcer scoring, and a part of the stomach mucosa 
was preserved in 10% formalin for histopathology. Another 
part of the stomach tissue was preserved in ice cold saline for 
estimation of mucin content. Stomach tissue homogenate was 
used for measuring reduced glutathione (GSH), super oxide 
dismutase (SOD), catalase and protein content.
Hypothermic Restraint Stress (HRS) induced ulcer
Rats were randomly divided in five groups of six subjects each, 
subjected to 24 h of fasting and orally treated as follows.
Group I: HRS + vehicle (1% CMC 0.5 ml/100 g)
Group II: HRS + omeprazole (20 mg/kg)
Group III: HRS + hesperidin (150 mg/kg)
Group IV: HRS + hesperidin (300 mg/kg)
Group V: HRS + hesperidin (450 mg/kg)
Animals of Group I were treated with vehicle 1% CMC (0.5 
ml/100 g) and all the other animals from Group II to V were 
administered with drugs in the above mentioned scheme for 
seven consecutive days, and 1 h before stress-induced ulcer 
induction on the 8th day of experiment. Rats were immobilized 
in a restraint cage at 4°C for 3 h (Senay and Levine, 1967). 
Stomach content was collected to measure pH, volume, total 
and free acidity, and stomach tissue was scored for ulcerative 
index, and mucin estimation, among other biochemical 
parameters measured on tissue homogenate.
Estimation of pH, gastric volume, total and free acidity
The gastric juice was collected and its volume was measured. 
The pH of the gastric juice was recorded using digital pH meter. 
Gastric content was centrifuged, diluted (1 ml diluted with 9 ml 
of distilled water) and clear supernatant was titrated against 
0.01 N NaOH, using Toper’s reagent till orange color, which 
corresponds to free acidity, and further titrated to pink color 
with phenolphthalein.  Total volume of NaOH corresponds to 
total acidity (Hawk, 1965). 
Acidity is expressed as: Vol. of NaOH × Normality × 100/0.1 
mEq/l/100 g.
Ulcer scoring and percentage inhibition
The number of ulcers per stomach was quantified and the 
severity of the lesions was observed microscopically.  The 
scoring of ulcers was done as described by Kulkarni (Kulkarni, 
2002), as 0 for normal colored stomach, 0.5 for red coloration, 1 
for spot ulcer, 1.5 for hemorrhagic streaks, 2 for ulcer between 
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at 580 nm, and the quantity of Alcian blue extracted per gram 
of glandular tissue was then calculated.
Statistical analysis
The results are presented as mean ± SEM. The data were 
analyzed by ANOVA (one-way analysis of variance). The 
statistical analysis was performed using Tukey-Kramer 
multiple comparison tests for all parameters. The values were 
considered significant at the levels of p < 0.05.
Results
Macroscopic characters of peel
Outer surface of fresh peel was bright greenish yellow, 
internally white. Dried peel was yellow with inner surface terse 
and white. The peels are irregular in shape and are found in the 
form of strips or pieces. The odor is aromatic and characteristic 
with aromatic bitter taste.
Phytochemical profile of methanol extract and isolated 
hesperidin
Methanol extract was obtained as semisolid brownish black 
mass with characteristic aromatic odour. The methanol 
extract gave positive result for the presence of carbohydrates, 
glycosides, steroids, tannins, flavonoids and polyphenols 
with absence of alkaloids having percentage yield of 18.12%. 
Isolated hesperidin was a light yellowish amorphous powder 
(yield 10.24%), it gave wine red color in ferric chloride test and 
bright violet color in Shinoda test as described by Hendrickson 
and Kesterson (1954). Melting point was found to be 245-246°C. 
Natural hesperidin normally extracted with its chalcone, which 
can vary the melting point from 243 to 257°C depending on 
different isolation conditions in contrast to chemically 
synthesized colorless hesperidin crystal melting at 261-262°C 
(Hendrickson and Kesterson, 1954).
Identification by TLC, UV, IR and HPLC of hesperidin
Sample hesperidin gave Rf value 6.1 compared to standard 
hesperidin 6.0 in solvent system n-butanol:acetic acid:water 
(4:1:5). The UV absorption maxima of isolated hesperidin were 
283.6 nm. The IR spectrum of isolated hesperidin showed 
a strong band of OHstr at 3378 cm
-1, CH aliphatic at 2924 
cm-1, C=C aromatic at 1608, 1516, 1447 cm-1, C=Ostr at 1648 
cm-1, C-Ostr at 1282, 1292, 1197, 1131, and 1093 cm
-1 similar 
to standard hesperidin (1). HPLC chromatogram showed 
retention time at 25.055 and 25.562 min for standard and 
isolated hesperidin, respectively.
Acute toxicity
Subjects were closely observed for 4 h, and for fourteen 
days afterwards for delayed toxicity. There was no sign of 
toxicity observed. It was concluded that lethal dose was 
higher than 2000 mg/kg. A dose range of 150-450 mg/kg, 
p.o. was selected for the evaluation of the pharmacological 
activity study as isolated hesperidin was free of acute oral 
toxicity.
Anti-ulcerogenic potential
Indomethacin caused induction of ulceration in sham treated 
animal, showing significant increase in pH (p < 0.001), volume 
of gastric content (p < 0.05), free and total acidity (p < 0.05-0.01), 
and with the ulcer index, 4.16 ± 1.29. The anti-ulcer property 
of hesperidin was evident from its extremely significant (p < 
0.001) reduction in total acidity and pH at 300 and 450 mg/kg 
doses compared with the sham group. Free acidity and ulcer 
index was reduced significantly (p < 0.01) at 450 mg/kg dose 
only. Hesperidin has non-significant effect on increased gastric 
content volume by indomethacin (Table 1).
The results in Table 2 showed significant reduction of GSH, 
SOD (p < 0.001) and catalase (p < 0.05) level in indomethacin 
treated group indicating toxicity of indomethacin at cellular 
level by reduction of free SH concentration. The protective 
Treatment  
(mg/kg)
Gastric juice
Ulcer index % protection
pH
Volume  
(ml/100 g)
Free acidity Total acidity
(Meq/l/100 g)
Vehicle control 3.34 ± 0.02 1.73 ± 0.02 9.67 ± 1.06 21.31 ± 2.40 - -
Indomethacin (25) 1.15 ± 0.04c 2.45 ± 0.24a 15.86 ± 2.36a 34.51 ± 3.66b 4.16 ± 1.29 -
Omeprazole (20) 5.06 ± 0.263 1.14 ± 0.08ns 5.59 ± 0.083 12.08 ± 1.243 1.16 ± 0.023 81.16
Hesperidin (150) 3.60 ± 0.083 1.93 ± 0.02ns 10.95 ± 2.25ns 22.64 ± 2.501 3.12 ± 0.03ns 32.46
Hesperidin (300) 4.06 ± 0.093 1.71 ± 0.04ns 9.54 ± 1.03ns 18.82 ± 2.123 2.57 ± 0.05ns 58.20
Hesperidin (450) 4.63 ± 0.133 1.68 ± 0.05ns 6.13 ± 0.932 15.14 ± 1.633 1.83 ± 0.062 70.22
Note. Values are expressed as Mean ± SEM six rat each treatment group. ap<0.05, bp<0.01 and cp<0.001 compared to vehicle control. 1p<0.05, 
2p<0.01 and 3p<0.001 compared to indomethacin treated group and ns = non-significant for both.    
Table 1
Effects of different concentration of essential oil of Piper aduncum L. on egg-hatching of Haemonchus contortus from sheep.
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Treatment  
(mg/kg)
GSH  
(Umol/g protein)
SOD 
(U/mg protein)
CAT 
(U/mg protein)
Mucin 
(μg/g gastric tissue)
Protein  
(mg/100 mg gastric tissue)
Vehicle control 3.24 ± 0.57 223.45 ± 12.02 18.63 ± 2.02 380.50 ± 15.14 16.82 ± 2.11
Indomethacin (25) 0.56 ± 0.01b 112.64 ± 10.64b 9.21 ± 1.57a 232.21 ± 14.05b 8.15 ± 1.45a
Omeprazole (20) 2.98 ± 0.463 219.23 ± 11.953 17.65 ± 2.251 392.68 ± 15.163 14.50 ± 2.86ns
Hesperidin (150) 0.64 ± 0.03ns 211.54 ± 12.333 12.34 ± 1.86ns 246.54 ± 13.28ns 10.19 ± 1.34ns
Hesperidin (300) 0.75 ± 0.02ns 216.65 ± 11.983 12.51 ± 1.05ns 255.28 ± 12.54ns 10.24 ± 1.58ns
Hesperidin (450) 1.85 ± 0.111 221.28 ± 13.733 18.28 ± 2.181 319.64 ± 13.172 13.85 ± 1.73ns
Note. Values are expressed as Mean ± SEM six rat each treatment group. ap<0.05 and bp<0.001 compared to vehicle control. 1p<0.05, 2p<0.01 and 
3p<0.001 compared to indomethacin treated group and ns = non-significant for both.
Table 2
Effect of hesperidin on biochemical parameters of indomethacin induced gastric ulcer on rats.
effect of hesperidin (450 mg/kg) was evident with the significant 
rise in the level of SOD (p < 0.001), GSH and catalase (p < 0.05), 
compared to the sham group. The normal level of mucin μg/
gm gastric tissue (380.50 ± 15.14) was extreme significantly 
reduced by indomethacin (232.21 ± 14.05) whereas hesperidin 
significantly normalized (319.64 ± 13.17) at 450 mg/kg dose 
comparable to omeprazole. Level of gastric tissue protein was 
also reduced by indomethacin and hesperidin was unable to 
affect it significantly. 
Unlike indomethacin HRS induced ulceration has not 
increased the volume of gastric juice, but elevated pH extreme 
significantly (p < 0.001). Free and total acidity was moderately 
(p < 0.05) elevated along with 5.16 ± 1.2 ulcer index. The anti-
ulcer property of hesperidin in HRS model is evident from its 
significant reduction in pH at all three doses (p < 0.001), and 
total acidity and ulcer index (p < 0.01-0.001) at 300 and 450 mg/
kg doses (Table 3). 
Hypothermic stress ulcer was involved with significant 
reduction of GSH (p < 0.01), but not SOD and catalase in 
combination with decrease in mucin and protein (p < 0.01-0.001 
respectively). Hesperidin treated animals showed significantly 
increased level of GSH, protein (0.05) and mucin (0.001) only at 
highest dose 450 mg/kg, other doses were ineffective (Table 4).
Gastric wall mucosa plays a main role in the protection 
of the gastric walls from aggressive factors that are 
responsible for gastric damage. The mucous layer forms a 
barrier between gastric wall and acid. Normal animal gastric 
mucosa showed clear and proper arrangement of cells (Figs. 
1A and 2A) in photographic representations. Indomethacin 
induced redness, spot and hemorrhagic ulcers (Fig. 1B). HRS 
induced moderate ulceration only with red strikes (Fig. 1E). 
Omeprazole at 20 mg/kg dose and hesperidin at 450 mg/kg 
dose nearly normalized mucosa only with redness (Figs. 1C, 
1D and 1F, 1G). 
Treatment  
(mg/kg)
Gastric juice
Ulcer index % protection
pH
Volume  
(ml/100 g)
Free acidity Total acidity
(Meq/l/100 g)
Vehicle control 3.34 ± 0.02 1.73 ± 0.02 9.67 ± 1.06 21.31 ± 2.40 - -
Indomethacin (25) 2.22 ± 0.02b 2.85 ± 0.94ns 10.86 ± 1.36a 31.51 ± 3.66a 5.16 ± 1.2 -
Omeprazole (20) 5.78 ± 0.043 1.34 ± 0.08ns 6.49 ± 0.08ns 16.08 ± 1.213 1.13 ± 0.023 78.30
Hesperidin (150) 3.50 ± 0.023 1.83 ± 0.02ns 9.95 ± 2.25ns 21.64 ± 2.40ns 4.12 ± 0.03ns 39.46
Hesperidin (300) 4.12 ± 0.083 1.71 ± 0.04ns 6.14 ± 1.03ns 17.82 ± 2.112 2.27 ± 0.052 58.53
Hesperidin (450) 4.73 ± 0.113 1.48 ± 0.05ns 4.23 ± 0.931 13.54 ± 1.643 2.03 ± 0.062 67.25
Note. Values are expressed as Mean ± SEM six rat each treatment group. ap<0.05 and bp<0.001 compared to vehicle control. 1p<0.05, 2p<0.01 and 
3p<0.001 compared to indomethacin treated group and ns = non-significant for both.    
Table 3
Effect of hesperidin on various parameters of hypothermic restraint stress (HRS) induced ulcer on rats.
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Figure 1 – Gastric mucosal layer. A, Stomach mucosa of vehicle control animal without any lesion or redness. B, The severely 
hemorrhagic mucosal layer of indomethacin-induced ulcerated animal; C and D, Omeprazole (20 mg/kg) and hesperidin (450 
mg/kg) significantly prevent hemorrhagic damage of the mucosa; E, Hypothermic Restraint Stress (HRS) induced moderate 
ulceration of the gastric tissue; F, The gastro-protective drug omeprazole (20 mg/kg) effectively normalizes damaged mucosal 
layer; G, The hesperidin (450 mg/kg) treated animal showed only some redness in gastric mucosa.
Treatment  
(mg/kg)
GSH  
(Umol/g protein)
SOD 
(U/mg protein)
CAT 
(U/mg protein)
Mucin 
(μg/g gastric tissue)
Protein  
(mg/100 mg gastric tissue)
Vehicle control 3.24 ± 0.57 223.45 ± 12.02 18.63 ± 2.02 380.50 ± 15.14 16.82 ± 3.11
Indomethacin (25) 1.51 ± 0.01a 197.61 ± 10.64ns 15.21 ± 1.57ns 213.21 ± 14.07b 6.13 ± 1.55a
Omeprazole (20) 2.84 ± 0.421 206.23 ± 12.95ns 16.65 ± 2.25ns 354.68 ± 14.162 12.50 ± 1.46ns
Hesperidin (150) 1.69 ± 0.02ns 210.51 ± 11.78ns 12.34 ± 2.86ns 244.54 ± 12.28ns 9.19 ± 1.34ns
Hesperidin (300) 1.77 ± 0.02ns 219.65 ± 12.74ns 14.43 ± 2.15ns 253.28 ± 11.54ns 10.24 ± 1.85ns
Hesperidin (450) 2.75 ± 0.131 224.28 ± 13.84ns 17.28 ± 2.19ns 318.54 ± 14.172 14.85 ± 1.781
Note. Values are expressed as Mean ± SEM six rat each treatment group. ap<0.01 and bp<0.001 compared to vehicle control. 1p<0.05 and 2p<0.001 
compared to indomethacin treated group and ns = non-significant for both.
Table 4
Effect of hesperidin on biochemical parameters of hypothermic restraint stress (HRS) ulcer on rats.
The histopathological observation showed damage 
and perforation of the gastric mucosal layer caused by 
indomethacin (Fig. 2B) in treated rat, whereas HRS induced 
hemorrhage and edematous appearance of the gastric tissue 
(Fig. 2E). Hesperidin-treated animals showed moderate 
recovery of mucosal damage in comparison to well organized 
mucosa of omeprazole against indomethacin (Figs. 2C and 2D). 
Omeprazole (20 mg/kg) and hesperidin (450 mg/kg) allowed 
regeneration but damage to the mucosa was only moderately 
recovered (Figs. 2F and 2G).
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Discussion
Plants are sources of some well known anti-ulcer drugs 
such as: liquorice (dehydroglycerrizinic acid), Piper betel L. 
(piperine), Emblica officinalis (embline), Terminalia bellerica and 
Terminalia chebula mostly in the category of glycosides and 
flavonoids (Maurya and Srivastava, 2011). Hesperidin (1) is a 
flavanone glycoside abundant in sweet orange and lemon, and 
is an inexpensive by-product of citrus cultivation. The present 
investigation was designed to explore the anti-ulcer activity 
of hesperidin isolated from C. sinensis on stress and oxidative 
damage-induced gastric ulcer models, looking into its potential 
antioxidant and anti-inflammatory properties. 
A peptic ulcer is an imbalance between aggressive factors 
and the maintenance of the mucosal integrity through the 
endogenous defense mechanism, although in most of the 
cases the etiology of ulcer is unknown (Bafna and Balaraman, 
2005). Although anti-ulcer treatment has improved, peptic 
ulcers along with their complication still involve significant 
mortality. The discovery of novel and more effective anti-
ulcer drugs is accompanied by the introduction of newer 
experimental methods to evaluate the anti-ulcer activity on 
different types of ulcers, and elucidation of their possible 
modes of action. Various mechanism are involved in ulcer 
production in different experimental models, hence it is not 
possible to assess anti-ulcer activity of a particular component 
studying a single mechanism (Parmar and Desai, 1993). 
The major underlying factor of ulcer formation is the 
generation of free radicals. Oxygen-derived free radicals play an 
important role in the pathogenesis of injury of various tissues, 
including the digestive system. In addition, involvement of 
oxygen free radicals such as the superoxide anion, hydrogen 
peroxide, and hydroxyl radical are well established in the 
pathogenesis of ischemic injury of gastrointestinal mucosa, as 
in other models of mucosal damage induced by indomethacin. 
Hypothermic restraint stress and indomethacin-induced stress 
activates free radical in the rat’s empty stomach, which further 
induces ulcer formation (Senay and Levine, 1967; Bhargava 
et al., 1973). The parameters used for the evaluation of anti-
ulcer activity were: ulcer index, pH, gastric volume, free and 
total acidity along with antioxidant defensive enzyme levels, 
and histopathology. Indomethacin induced ulceration was 
associated with the increase in the gastric volume, free acidity, 
total acidity, ulcer index and decreases in pH, GSH, SOD, 
catalase, mucin and protein, compared to the control group. 
Indomethacin inhibits the synthesis of cytoprotective 
prostaglandins, induced by COX-1 and COX-2 in the gastric 
tissue (Whittle, 1981). Reactive oxygen species (ROS) possess an 
important role in the pathogenesis of mucosal damage caused 
by indomethacin, ethanol and other irritating agents besides 
the inhibition of COX enzymes (Terano et al., 1989; Yoshikawa 
et al., 1993). Hesperidin at 300 and 450 mg/kg dose significantly 
increased the pH, and decreased total and free acidity, as well 
as ulcer index on indomethacin-induced ulcerated rat stomach. 
Figure 2 – Histopathologic photomicrograph of gastric mucosal layer. A, Stomach mucosa of vehicle control animals showed 
clear and proper arrangement of cells; B, The cells were damaged and created opaque regions in gastric mucosa of indomethacin-
induced ulcer animal groups; C, The standard gastro-protective drug omeprazole (20 mg/kg) effectively restores damaged cells 
of gastric mucosa layer; D, The hesperidin (450 mg/kg) treated animal showed regeneration of ulcerative cells and moderately 
arranged layer in gastric mucosa; E, Degeneration, hemorrhage and edematous appearance of the gastric tissue in Hypothermic 
Restraint Stress (HRS) induced ulcer model were shown in figure. F and G, Omeprazole (20 mg/kg) and hesperidin (450 mg/kg) 
showed regeneration and prevented the formation of hemorrhagic damage and edema but with damaged mucosa.
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In the present study, the level of GSH, SOD, catalase, mucin 
and protein level was significantly reduced by indomethacin in 
rat’s gastric tissues. Indomethacin, like non-steroidal analgesic 
and anti-inflammatory drugs, is reported to decrease the level 
of GSH, SOD and catalase in tissue (Takeuchi et al., 1991; Dengiz 
et al., 2007). The reduced level of GSH, SOD, catalase, mucin 
and protein was also significantly elevated by hesperidin at 
450 mg/kg dose. Hesperidin at 300 and 450 mg/kg dose showed 
58.20 and 70.22% ulcer protection, respectively, indicating its 
cytoprotective effect.
HRS induces ulceration by implementing both emotional 
as well as physiological stress. Stress provokes release of free 
radicals, which causes mucosal cell damage, and instability 
of antioxidant enzyme status (Das and Banerjee, 1993). HRS 
induced ulcerated animals showed an increase of free and 
total acidity, and ulcer index, along with a decrease in pH 
while volume of gastric content was unaffected. GSH acts 
as an important endogenous defensive substance against 
the ROS and its level was found to be reduced in rats 
subjected to HRS (Sahin and Gumuslu, 2007). Stress caused 
both sympathetic and parasympathetic stimulation of the 
stomach leading to local hypoxia. The GSH level was found 
to be significantly reduced in rats subjected to stress along 
with mucin and protein. The ischemic condition caused an 
increase in the levels of H2O2, which in conjugation with 
O2 generates OH
- ions, which oxidized various cellular 
constituents such as proteins, and membrane lipids. Lipid 
peroxidation causes loss of membrane fluidity and allows 
the emergence of ulcers (Tandon et al., 2004). Though HRS 
is reported to reduce thiobarbituric acid reactive substance 
(TBARS), GSH, SOD and catalase (Sood et al., 2010), in the 
present study HRS did not affect SOD and catalase levels 
but decreased GSH, mucin and protein levels significantly. 
Hesperidin at 450 mg/kg dose showed 67.25% protection 
against stress induced ulceration with effective reduction in 
pH, acidity, mucin and protein level. Hesperidin in both the 
models had no significant effect on volume of gastric content 
indicating absence of anti-secretory effect. 
Macroscopic and histopathological evidence showed 
that 450 mg/kg dose of hesperidin protected mucosal layer 
from spot and hemorrhagic ulcers caused by indomethacin 
and hypothermic stress, and also reduced the damage to 
glandular tissue of stomach wall. Gastric mucosa plays a 
vital role in the protection of gastric wall from aggressive 
factors responsible for damage by forming a barrier (Hills, 
1993). Integration of mucosa essentially provides protection 
to the inner glandular and muscular layer of stomach wall. 
Hesperidin treatment not only maintained gastric mucosa 
but also helped in the regeneration of the damaged region, 
proving its cytoprotective effects by maintaining efficient 
gastric mucosal microvascular integrity.
Results indicate that a low dose of hesperidin (150 mg/
kg) was not effective in treating ulcer, a medium dose was 
moderately effective compared to omeprazole but the higher 
dose 450 mg/kg very efficiently protects the stomach from 
ulcers due to its antioxidant activity. Ulcer index is one of 
the confirmatory parameters of ulcerogenesis by noxious 
elements. HRS induced more severe ulceration compared 
to indomethacin whereas oxidative damage was more 
evident with indomethacin. Several mechanisms have 
been proposed to explain the gastro-protective effect 
of flavonoids, among them are: free radical scavenging, 
increase in mucosal prostaglandin content, improvement 
in gastric tissue microcirculation and cytoprotection, for 
which flavonoids could have a therapeutic potential ideal 
for treatment of gastrointestinal diseases. Hesperidin (1), the 
most abundant natural flavonoids, prevents oxidative injury 
and cell death by scavenging oxygen radicals, protecting 
against lipid peroxidation and chelating metal ions (Fraga 
et al., 1987; Korkina and Afanas’ev, 1997; Miller and Rice-
Evans, 1997). The study outcome proposes that anti-ulcer 
effect of hesperidin is due to antioxidant, mucoprotective 
and cytoprotective effects on gastric mucosa but no anti-
secretory effect.
Conclusion
All these observations emphasize the potential ulcer 
protective effect of hesperidin against indomethacin 
and HRS, which is associated with antioxidant and free 
radical scavenging ability in the stomach mucosal tissue. 
Antioxidant potential has played a significant role in 
preventing ulcer by hesperidin as the ulcer protection was 
higher against indomethacin which produces ulceration 
primarily due to local oxidative damage. Hypothermic 
stress ulceration depends not only on hypoxic damage but 
also on the activation of autonomic nervous system. In this 
case, hesperidin has moderate effect as it may not inhibit 
the autonomic system related activated hypersecretory 
response in gastric mucosa. Detailed molecular and 
receptor level mechanistic studies are required to explore 
the potential anti-ulcer therapeutic applicability of 
hesperidin. 
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